Our current findings provide the first evidence of drebrin expression and interaction with the growth factor progranulin in urothelial-carcinoma derived cells where drebrin exerts an essential role in modulating progranulin-induced biological responses. The gene discussed is DBN1; the disease is urothelial carcinoma.